Nitin Kataria: Can We Predict Oocyte Quality Before IVF?
Nitin Kataria, Senior Clinical Embryologist and Quality Manager at Indira IVF Group, shared a post on LinkedIn:
“Can We Predict Oocyte Quality Before IVF?
As embryologists, we spend countless hours evaluating embryos. But one question continues to challenge reproductive medicine:
Can we predict oocyte (egg) quality before IVF even begins?
The short answer: partially, but not perfectly.
Despite major advances in reproductive science, there is still no single test that can accurately determine the developmental competence of an individual oocyte before fertilization.
What Do We Currently Use?
Several markers help us estimate the likelihood of obtaining good-quality oocytes:
1. Maternal Age
- The strongest predictor of oocyte competence.
- As age increases, mitochondrial dysfunction and chromosomal abnormalities become more common.
2. AMH and AFC
- Useful indicators of ovarian reserve.
- However, they predict quantity better than quality.
3. Lifestyle and Metabolic Health
- Obesity, smoking, oxidative stress, poor sleep, and uncontrolled metabolic disorders can negatively affect oocyte competence.
4. Hormonal Environment
- Androgen excess, insulin resistance, and altered follicular microenvironments can impact oocyte maturation.
The Emerging Science
Researchers are now exploring more advanced predictors:
1. Follicular Fluid Biomarkers
- Oxidative stress markers
- Cytokines
- Metabolites
2. Mitochondrial Function
- Oocytes require enormous amounts of energy for fertilization and embryo development.
- Mitochondrial health may be one of the most important determinants of egg quality.
3. Artificial Intelligence
- AI-driven analysis of ovarian imaging and patient data may improve prediction models in the future.
4. Omics Technologies
- Proteomics, metabolomics, and transcriptomics are helping us understand the molecular signatures associated with competent oocytes.
The Reality Check
One of the biggest misconceptions in IVF is that a high ovarian reserve automatically means high-quality eggs. It doesn’t. A patient may produce
25 oocytes with poor developmental potential, or 8 oocytes with excellent developmental competence.
Quantity and quality are not the same thing.
What This Means for IVF
The future of IVF is shifting from simply counting follicles to understanding the biology inside them.
The goal is no longer just:
How many eggs can we retrieve?
The more important question is:
Which eggs have the highest chance of creating a healthy embryo and ultimately a healthy baby?
We are getting closer to answering that question, but we’re not there yet.
As a senior embryologist, I believe the next major breakthrough in IVF won’t come from producing more oocytes it will come from accurately identifying the most competent ones before fertilization ever occurs.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 14, 2026, 09:08Madhur Hamine: Maharashtra Can Become India’s IVF Medical Value Tourism Capital
-
Jun 14, 2026, 08:56Francine Freitas Fernandes: Deep Endometriosis With Appendiceal Involvement Identified on Specialized Ultrasound
-
Jun 14, 2026, 08:43Shilpa Sharma: Women Taking CoQ10 Before IVF Showed Improved Egg Quality and Mitochondrial Function
-
Jun 14, 2026, 08:26ESGO Calls for Greater Awareness of Rising Endometrial Cancer Rates – ESGO
-
Jun 14, 2026, 06:13George Koustas: Are Current Certification Examinations Truly Assessing Readiness?
-
Jun 14, 2026, 05:37Aumatma Simmons: IVF Should Not Automatically Be the First-Line Intervention for Infertility
-
Jun 14, 2026, 05:24Sergio Haimovich: Can Pipelle-Induced Endometrial Injury Modify the Uterine Environment in Women with RIF
-
Jun 13, 2026, 18:55Khalil Faaed: The Next Revolution in IVF May Not Be AI or PGT-A It May Be Piezo-ICSI
-
Jun 13, 2026, 18:49Some Exciting Research, Reviews, Perspectives, and Editorial in Our June Issue – The Lancet Obstetrics, Gynaecology, and Women’s Health